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Abstract
Background: Endothelial control of vascular smooth muscle plays a major role in the resulting vasoreactivity implicated in
physiological or pathological circulatory processes. However, a comprehensive understanding of endothelial (EC)/smooth
muscle cells (SMC) crosstalk is far from complete. Here, we have examined the role of gap junctions and reactive oxygen
species (ROS) in this crosstalk and we demonstrate an active contribution of SMC to endothelial control of vasomotor tone.
Methodology/Principal Findings: In small intrapulmonary arteries, quantitative RT-PCR, Western Blot analyses and
immunofluorescent labeling evidenced connexin (Cx) 37, 40 and 43 in EC and/or SMC. Functional experiments showed that
the Cx-mimetic peptide targeted against Cx 37 and Cx 43 (
37,43Gap27) (1) reduced contractile and calcium responses to
serotonin (5-HT) simultaneously recorded in pulmonary arteries and (2) abolished the diffusion in SMC of
carboxyfluorescein-AM loaded in EC. Similarly, contractile and calcium responses to 5-HT were decreased by superoxide
dismutase and catalase which, catabolise superoxide anion and H2O2, respectively. Both Cx- and ROS-mediated effects on
the responses to 5-HT were reversed by L-NAME, a NO synthase inhibitor or endothelium removal. Electronic paramagnetic
resonance directly demonstrated that 5-HT-induced superoxide anion production originated from the SMC. Finally, whereas
5-HT increased NO production, it also decreased cyclic GMP content in isolated intact arteries.
Conclusions/Significance: These data demonstrate that agonist-induced ROS production in SMC targeting EC via
myoendothelial gap junctions reduces endothelial NO-dependent control of pulmonary vasoreactivity. Such SMC
modulation of endothelial control may represent a signaling pathway controlling vasoreactivity under not only
physiological but also pathological conditions that often implicate excessive ROS production.
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Introduction
In vessels, smooth muscle cell (SMC) responses are controlled by
endothelial cells (EC) via complex intercellular signaling processes.
Regarding vascular tone, the best described interaction is the
endothelial-dependent vascular relaxation through the release of
nitric oxide (NO) and vasoactive prostanoids [1]. Another pathway
is associated with the hyperpolarization of both the EC and SMC
and mediated by an endothelium-derived hyperpolarizing factor
(EDHF). Whereas EDHF identity is still under debate and may
differ among species and vascular segments, there is evidence that
EDHF-mediated responses involve epoxyeicosatrienoic acids
(EETs) [2], potassium ions and channels [3], reactive oxygen
species (ROS) such as hydrogen peroxide (H2O2) [4] and
myoendothelial junctions [5].
In the pulmonary circulation, endothelial control of smooth
muscle tone is of critical importance to maintain low pressure and
low resistance. In this connection, most of the medical treatments
used in pulmonary hypertension (e.g., NO, prostacyclin…) mimic
and amplify the physiological control of EC on SMC. For
instance, serotonin (5-HT), a potent vasoconstrictor whose
concentration is increased in pulmonary arterial hypertension
(PAH) [6,7], acts on both SMC and EC. On one hand, 5-HT can
generate NO in pulmonary arterial EC [8]. On the other hand, 5-
HT produces ROS in bovine and mice pulmonary arterial SMC
and the production of superoxide anion (O2
N -) facilitates 5-HT-
induced pulmonary vasoconstriction [9,10]. O2
N - can interact with
NO to produce peroxynitrite which decreases endothelial NO
synthase (eNOS) expression and/or loss of eNOS substrate L-
arginine or cofactors tetrahydrobiopterin (BH4) [11]. We thus
hypothesized an EC/SMC crosstalk through NO and O2
N -. Gap
junctions mediate intercellular communication between EC and
SMC (myoendothelial gap junctions) and allow direct exchange of
ions and small molecules in various tissues including pulmonary
arteries [5,12]. Whereas gap junctions are expressed in pulmonary
artery [13,14], participate to vascular tone in general [12] and are
stimulated by 5-HT in coronary and mesentery SMC [15], no
study has been performed on the role of gap junctions in the
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may well participate to the EC/SMC crosstalk. Interestingly,
resistance vessels are very important for blood flow regulation and
the incidence of myoendothelial gap junctions is higher in
resistance than in conduit arteries [16].
In the present study, we have therefore addressed, in small
intrapulmonary arteries (IPA), the issue of expression, localization
and function of the connexins (Cx) 37, 40 and 43 which are the Cx
usually expressed in small vessels. Peptides homologous to the gap
26 and 27 domains of the extracellular loops of Cx 43 (
43Gap 26)
or Cx 37 and 43 (
37-43Gap 27) respectively, interrupt intercellular
communications in a Cx-specific manner and attenuate the
calcium and contractile responses to 5-HT. Such effect was
reversed by (1) the removal of the endothelium-dependent NO
function or (2) the decrease of ROS production. Electronic
paramagnetic studies demonstrated that ROS and more specifi-
cally O2
N - was produced by the smooth muscle in response to 5-HT.
In the same way, the NO and cyclic GMP content were assessed in
response to 5-HT.
Altogether, the findings suggest that 5-HT produces O2
N - in the
smooth muscle and NO in the endothelium. O2
N - passes through
the myoendothelial junctions to decrease endothelial NO
production and thus strengthen pulmonary vasoreactivity. This
is the first time that a negative control of the endothelial NO
function by the smooth muscle is demonstrated. Since ROS
production is increased in many cardiovascular diseases, such
process could be of great importance under pathological
conditions.
Materials and Methods
Ethics Statement
All animal work has been conducted according to relevant
international and national guidelines in accordance with the
recommendations of the Weatherall report, ‘‘The use of non-
human primates in research’’. All the protocols used were
approved by our local ethics committee named Comite ´ d’e ´thique
re ´gional d’Aquitaine. The protocol number is AP 2/11/2005.
Tissue Preparation
Male Wistar rats (10–15 weeks old, weighing 300–400 g) were
sacrificed using CO2 asphyxia according to the animal care and
use local committee (Comite ´ d’e ´thique re ´gional d’Aquitaine – AP
2/11/2005). The left lung was rapidly removed and rinsed in
Krebs–HEPES–bicarbonate containing (in mM): 118.4 NaCl, 4.7
KCl, 1.2 MgSO4, 4 NaHCO3, 1.2 KH2PO4, 2 CaCl2, 10 N-2-
hydroxyethylpiperazine-N’-2-ethanesulfonic acid (HEPES) and 6
D-glucose, pH 7.4 with NaOH. Intrapulmonary arteries with an
external diameter of 300–350 mm (IPA) were then dissected free
from surrounding connective tissues under binocular control.
Intracellular Calcium and External Diameter Recording
IPA were cannulated as previously described [17] in an
arteriograph (DMT, Denmark). Residual blood was removed by
perfusing the vessels with Krebs-HEPES solution, and then vessels
were maintained in a no-flow state and held at a constant
transmural pressure of 10 mmHg and at a constant temperature of
37uC. Vessels were incubated 1 h in 2 mM Fura-PE3-AM at 37uC
and rinsed for 10 min with Krebs-HEPES solution. The
arteriograph was then placed on the stage of an inverted
epifluorescence microscope (Olympus IX70) equipped with a
x10, UPlanApo/0.40 W water-immersion objective (Olympus).
The source of excitation light was a xenon arc lamp (175 W), and
excitation wavelengths were selected by a wheelfilter (Sutter
Instrument Co.) composed of 345 nm and 380 nm filters. Digital
images were sampled at 12-bit resolution by a fast-scan, cooled
charge-coupled device camera (CoolSNAP fx Monochrome,
Photometrics). Preparation was then alternately excited at 345
and 380 nm and emission fluorescence at 510 nm of both
excitation wavelengths was imaged every 20 seconds. As previ-
ously described, regions of interest were drawn on the vascular
wall to determine calcium signal from smooth muscle cells and
background was substracted using MetaFluor (Universal Imaging
Software) [17]. External diameter of the vessels was measured on
these images using MetaMorph (Universal Imaging Software).
Contraction was expressed as a percentage related to the
percentage of decrease of the initial external diameter.
Either 10 mM or cumulative concentrations of 5-HT (Sigma)
were added to the bath, which was bubbled with air. After
recording of this first contraction, vessels were washed and
pharmacological substances were added both to the bath and to
the perfusion solution inside the vessel for one hour. We inhibited
gap junction communications through Cx 37 and Cx 43, Cx 40, or
Cx 43 with synthetic connexin-mimetic peptides:
37,43Gap 27
(SRPTEKTIFII),
40Gap 27 (SRPTEKNVFIV) and
43Gap 26
(VCYDKSFPISHVR) respectively (Genscript). Specificity of these
peptides was checked with an inactive homologous peptide:
43Gap
20 (EIKKFKYGC). The role of superoxide anion was investigated
with 300 U/ml poly-ethylene glycol-superoxide dismutase (PEG-
SOD, Sigma) combined to 600 U/ml poly-ethylene glycol-catalase
(PEG-catalase; Sigma). Once substances added, a second contrac-
tion with either 10 mM or cumulative concentrations of 5-HT was
performed. We performed time-matched controls to check that we
can produce two similar cumulative concentration-response curves
(CCRC) to 5-HT with one hour of delay between the two CCRC
(Figure S1). When indicated, vessels were perfused before
contraction protocol with 100 ml of 0.3% 3-((3-cholamidopropyl)-
diethylammonio)-1-propane sulphonate (CHAPS, Sigma) in order
to remove endothelium, as previously described [18].
We checked that such protocol suppressed endothelial function
by testing the absence of a relaxation with 10 mM carbamylcholine
of 40 mM KCl-induced preconstricted pulmonary arteries (Figure
S2). CHAPS on its own had no deleterious effect on the
contraction and calcium signal induced by high potassium solution
(KCl 40 mM) (Figure S3).
Isometric Contraction Measurements
Isometric contraction was recorded in intrapulmonary arterial
rings with an external diameter of 1.5–2 mm as reported
previously [19,20]. Briefly, mechanical properties were assessed
using organ bath and transducer systems, coupled to IOX software
(EMKA Technologie). As determined in preliminary experiments,
tissues were set at optimal length by equilibration against a passive
load of 0.8 g. At the outset of each experiment, K
+-rich (80 mM)
solution, obtained by substituting an equimolar amount of KCl for
NaCl from Krebs-HEPES solution, was applied in order to obtain
a reference contraction used to normalize subsequent contractile
responses. Contractile properties were tested by constructing a
CCRC to 5-HT (10 nM to 100 mM) for each ring. When
indicated,
37,43Gap 27 was incubated during 1 hour before CCRC
to 5-HT.
Endothelial function was tested by relaxation with 10 mM
carbamylcholine of 0.3 mM phenylephrine-induced preconstricted
pulmonary arterial rings. All experiments were performed at 37uC.
Quantitative RT-PCR
RNA Extraction. IPA from one rat was homogenized using
600 ml of Trizol (Invitrogen), then, 120 ml of chloroform (Sigma)
Modulation of Vasoreactivity
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centrifugation at 15,000 g for 15 min. RNA was precipitated in the
presence of isopropanol (Sigma) at 220uC overnight. The pure
RNA was obtained by centrifugation at 15,000 g for 15 min and
was washed with 80% ethanol (Sigma). The concentration of RNA
was measured spectrophotometrically by GeneQuant RNA/DNA
calculator (Amersham Pharmacia). The total RNA (1 mg) was
reverse transcribed into cDNA by using AMV reverse
transcriptase (Promega), RNase inhibitor, and oligo d(T) as a
primer at 42uC for 60 min followed by heating at 94uC for 3 min.
Real-time Quantitative Polymerase Chain Reaction
(PCR). Real-time quantitative PCR was performed with a
Rotor-Gene 2000 (Corbett Research). Triplicate PCR reactions
wereassembledin0.1-mlstriptubescontainingcDNAfrom10 ngof
total RNA,0.2 mlo f5 0 6Titanium Taq DNA Polymerase combined
to its buffer (Clontech Laboratories), 1 mM dNTP, each of the
appropriate primer (Sigma Genosys; see table 1 for concentrations
and sequences), and 0.56SYBR Green (Molecular Probes).
The PCR was performed under the following conditions:
denaturation at 95uC for 15 s, annealing temperature (68–70uC)
depending on specific primers for 15 s, and extension at 70uC for
15 s, these steps were repeated during 40 cycles. Data collection
was performed after each extension step, at a temperature of at
least 3.5uC lower than the melting temperature of the amplicon
(generally between 80–85uC) to eliminate non-specific fluores-
cence signal. PCR negative controls were systematically made by
using water instead of cDNA. All specific primers were designed
by using the primer analysis software (Oligo 6.6, Molecular
Biology Insights). The efficiency of the PCR reactions was always
more than 90%. Specificity of the amplified PCR products was
checked with melting curve analysis and by electrophoresis
analysis on a 2% agarose gel containing SYBR Green.
Western Blot
IPA from 4 rats were homogenized on ice in lyses buffer
containing 1% IGEPAL, 0.5% sodium deoxycholate, 0.1% SDS,
1 mM amino-ethyl-benzenesulfonyl fluoride hydrochloride
(AEBSF),1.5 mM aprotininand 0.1 mMleupeptin(Sigma-Aldrich).
After 10 minutes of centrifugation at 15,000 g, supernatant is
reduced in Laemmli buffer and heated at 90uC for 6 min. Protein
extract were subjected to electrophoresis on a 10% acrylamid
reducing gel, and transferred to polyvinylidene fluoride (PVDF)
membranes (Immobilon-P, Millipore). The immunoblots were then
incubated using either rabbit anti-Cx 37, rabbit anti-Cx 40 or
mouse anti-Cx 43 (Zymed) overnight at 4uC. After incubation with
appropriate secondary antibodies coupled to horseradish perox-
ydase (HRP, Santa Cruz) for 2 h at room temperature, immuno-
blots were then revealed by enhanced chemiluminescence acquired
using Kodak Image Station 4000 MM. Band densities were
quantified using GeneTool software (SynGene). Immunoblots were
then stripped and revealed with mouse anti-b-actin for 1 h at room
temperature.
Immunofluorescence
IPA were fixed in Formalin (Sigma) for 10 min and then
embedded in OCT-Compound, frozen at -20uC and cut in 10 mm
sections with a cryostat. Sections were first incubated in 0.1%
Triton X-100 (Sigma) and 1% bovine serum albumin in PBS for
1 h at room temperature, and then in the primary antibodies
(same antibodies as the ones used for Western Blot) overnight at
4uC. Sections were then incubated with the appropriate secondary
antibodies coupled to Alexa 546 (Molecular Probes) for 2 h at
room temperature. Nuclei were labeled with 45 mM Hoechst
33342 (Molecular Probes). Sections were then observed with a
laser scanning confocal microscope TE2000 (Nikon) with a x 60,
1.40 NA plan apochromat oil-immersion objective. Excitation was
obtained with a diode laser at 408 nm to observe nuclei, an argon
laser at 488 nm to observe autofluorescence of the internal elastic
lamina and a helium-neon laser at 543 nm to observe Cx labeling.
The emitted light was filtered as appropriate: 450635 nm for
nuclei (blue), 515630 nm for internal elastic lamina (green), and
605675 nm for Cx labeling (red).
Dye Transfer
IPA were mounted in an arteriograph as previously described
(see Intracellular calcium and external diameter recording). The
vessels were allowed to equilibrate and pressurized at 10 mmHg
for 30 min, and then lumen was loaded with 10 mM carboxy-
fluorescein-AM (Molecular Probes) for 30 min before washout
with Krebs-HEPES for 30 min. Where indicated, vessels were
perfused with 300 mM
37,43Gap 27 for 1 h before carboxyfluor-
escein loading. Vessels were subsequently removed from the
Table 1. Sequences of the primer pairs (S: sense; AS: antisense) for housekeeping genes (GAPDH, HPRT, PLRPO and YWHAZ) and
genes of interest (Cx 37, Cx 40 and Cx 43) are shown as well as GenBank accession number, product length, product Tm and
concentrations.
Gene Sequence GenBank accession number Product length (pb) Product Tm (uC) Concentration (nM)
GAPDH S: ATTCTACCCACGGCAAGTT
AS: CGCCAGTAGACTCCACGACATA
NM_017008 153 89.4 200
HPRT S: TGTTGGATATGCCCTTGACTA
AS: AGATGGCCACAGGACTAGAAC
NM_012583 178 85.6 100
PLRPO S: AGGTGGGAGCCAGCGAAGC
AS: GCAACAGTCGGGTAGCCAATC
NM_022402 208 91.7 100
YWHAZ S: AGCCGAGCTGTCTAACGAG
AS: GCCAAGTAGCGGTAGTAGTCA
NM_013011 291 88.4 100
Cx 37 S: GGTGGCAGAGGACGGTCGTCT
AS: CCATGGTCCAGCCGTAGAGA
NM_021654 133 85.3 200
Cx 40 S: GGAAAGAGGTGAACGGGAAG
AS: GGGCCTCGAGACATAACAGTT
NM_01280 197 91.3 200
Cx 43 S: TCTGCCTTTCGCTGTAACACT
AS: GGGCACAGACACGAATATGAT
NM_012567 117 87.5 200
doi:10.1371/journal.pone.0006432.t001
Modulation of Vasoreactivity
PLoS ONE | www.plosone.org 3 July 2009 | Volume 4 | Issue 7 | e6432arteriograph and fixed in Formalin for 20 min at room
temperature before cryopreservation in OCT compound at
220uC. Cryosections (10 mm thick) were prepared and mounted
in Fluorescent mounting medium (Dako) and imaged with laser
scanning confocal microscope TE2000 (Nikon) with a x 60, 1.40
NA plan apochromat oil-immersion objective. Preparation was
excited with an argon laser at 488 nm, and fluorescence emission
was filtered at 515 nm630.
Electron Paramagnetic Resonance (EPR) Recordings
Intrapulmonary arteries with an external diameter of 0.3–2 mm
were used for EPR studies and cGMP measurements.
Superoxide Anion Spin Trapping. Pulmonary arteries were
incubatedinthespin trapsolution containing500 mM1-hydroxy-3-
methoxycarbonyl-2,2,5,5-tetramethylpyrrolidin (CMH, Noxygen),
25 mM deferoxamine (Sigma) and 5 mM N,N-diethyldithio-
carbamate (DETC, Sigma) in Krebs-HEPES at 37uC for 45 min.
5-HT 0.1 mM was added during the spin trap incubation; PEG-
SOD 300 U/mL was incubated during 45 min before spin trap
incubation. Reaction was stopped by freezing the sample in liquid
nitrogen. Samples were then analyzed by EPR spectrometry on a
tabletop x-band spectrometer miniscope (MS200, Magnettech).
Spectra of the oxidized product of CMH (CMN) were recorded at
77uK using a flask Dewar. Acquisition parameters were as followed:
Bo Field: 33416150 G, microwave power: 10 dB, amplitude
modulation: 5 G, sweep time: 60 sec, gain: 300 and 3 scans [21].
Signals were quantified by measuring the total amplitude, after
correction of baseline and normalized to the protein quantity of the
sample in mg/ml.
NO Spin Trapping. Detection of NO production was
performed using the technique with Fe
2+-DETC as spin trap.
IPA were placed in 0.5 ml of Krebs-HEPES and then treated with
0.5 ml of colloid Fe(DETC)2 as previously described and
incubated for 45 min at 37uC [22]. When indicated, 0.1 mM 5-
HT was added during Fe(DETC)2 incubation. NO measurements
were performed at 77uK using EPR spectrometry. Instrument
settings were: Bo Field: 3285680 G, microwave power: 10 dB,
amplitude modulation: 7 G, sweep time: 150 sec, gain: 900 and 3
numbers of scan. Signals were quantified by measuring the total
amplitude, after correction of baseline and normalized to the
protein quantity of the sample in mg/ml.
cGMP Measurements
Intrapulmonary arteries were incubated in Krebs-HEPES with
or without 5-HT 0.1 mM and with or without PEG-SOD + PEG-
catalase (300 U/ml and 600 U/ml respectively) at 37uC for
15 min, cooled in liquid nitrogen and then stored at 280uC.
Arteries were homogenized in ice-cold trichloroacetic acid (5%,
Sigma) to extract cGMP. cGMP content was assayed as described
in the procedure of an ELISA kit obtained from Cayman
Chemical & Co. cGMP level was normalized to tissue protein
content in mg/ml.
Statistical Analysis
All results are expressed as means6SEM, n indicates the
number of IPA for the calcium and contractile studies, dye transfer
and immunofluorescence, the number of rats for quantitative RT-
PCR, EPR and cGMP measurements, and the number of
experiments from 3 pools of rats (4 rats per pool) for Western
Blot. Cumulative concentration response curves to 5-HT were
fitted to the logistic equation with Origin 6.0 software to determine
the maximum effect of 5-HT for each experiment, and a non
parametric test for paired samples (Wilcoxon test) was performed
on the maximum effect of 5-HT with or without drug.
Quantitative RT-PCR results were analyzed with the GeNorm
method [23]. Statistical analyses were performed on all other data
using a non parametric test for unpaired samples (Mann-Witney
test). Values of P,0.05 were considered significant.
Results
Connexins 37, 40 and 43 are expressed and functional in
the pulmonary arterial wall
Although very few studies have been performed with contro-
versial results in pulmonary arteries, the three Cx 37, 40 and 43
have been observed in pulmonary arteries [13,14]. Quantitative
RT-PCR and Western Blot experiments evidenced the presence of
the mRNA and proteins for the three Cx 37, 40 and 43 in small
intrapulmonary arteries (IPA) (Figure 1A and B). Immunofluores-
cent labeling studies confirmed the presence of the Cx 37, 40 and
43 proteins (Figure 1C). The autofluorescence of the external and
internal elastic lamina in green has been previously observed in
various vessels [24,25] and is useful to delimit the smooth muscle
layers from the endothelial cells and the adventitia. Some punctate
labeling was observed for the Cx 37, 40 and 43 in the endothelium
and similar labeling was observed in the smooth muscle for the Cx
37 and 40 (Figure 1C). Punctate staining is characteristic of
connexins labeling and has been previously shown in various
tissues including vessels [4,24,25]. Since (1) Cx 37 and 43 are
expressed in IPA, (2) they have a functional role in both the
calcium and contractile signal and (3) they are localized in the
endothelium, we then addressed the functional role of the Cx 37
and 43 in the myoendothelial communications and/or the
communications between endothelial cells. After loading endothe-
lial cells with a fluorescent dye (carboxyfluorescein), the dye
diffused to the smooth muscle cells in control conditions (Figure 1D
left) whereas it stayed in the endothelium when the vessels were
pretreated with
37,43Gap 27 300 mM (Figure 1D right).
Altogether, it can be concluded that the myoendothelial
communications are functional and involve the Cx 43 and/or
Cx 37.
Vasoreactivity to 5-HT is controlled by gap junctions and
endothelium
We then examined if gap junctions had any influence on (1) the
intracellular calcium concentration in smooth muscle and (2) the
contraction in IPA. Consequently, we checked if any of these
connexins had any role in the simultaneously recorded calcium
and contractile signals in response to the agonist 5-HT in IPA.
Incubation of the vessels with
40Gap 27 300 mM, the Cx-mimetic
peptide used as a specific blocker of the Cx 40, had no effect on
both calcium and contractile signals (Figure S4). In contrast,
incubation with
37,43Gap 27 300 mM, the Cx-mimetic peptide
used as a specific blocker of the both Cx 37 and 43, strongly
decreased both calcium and contractile signals to 5-HT (Figure 2A
and B left). Incubation with
43Gap26 300 mM, the specific blocker
of the Cx 43 alone, had similar effects on calcium and contractile
signals to those of the
37,43Gap 27 (Figure S5) suggesting that the
Cx 43 is involved in the response to 5-HT. Since
43Gap 20 is a
peptide homologous to the intracellular loop of the Cx 43, it can
be used as an inactive analog of the Gap 27 specific of the Cx 43
[26]. We observed that
43Gap 20 300 mM had no effect on the
calcium and contractile signals to 5-HT confirming the specificity
of these Cx-mimetic peptides (Figure S6).
Since gap junctions are localized in between smooth muscle
cells and/or in between endothelial cells and/or in between
smooth muscle and endothelial cells (myoendothelial junctions),
we removed the endothelium of the vessels to discriminate the role
Modulation of Vasoreactivity
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the
37,43Gap 27 300 mM was absent in endothelium-denuded
vessels (Figure 2B right) suggesting that the myoendothelial and/or
the endothelial junctions are important for the calcium and
contractile signals to 5-HT.
Isometric tension recordings showed that whereas
37,43Gap 27
300 mM blocked the CCRC to 5-HT (0.01–100 mM), it had no
effect on the CCRC to phenylephrine (0.1 nM–3 mM), to
endothelin-1 (0.1–5000 nM) and to high potassium solutions (4.7–
100 mM, Figure S7). Moreover, in systemic vessels such as renal
arteries, the CCRC to 5-HT were identical in the presence or in the
absence of
43Gap 26 300 mM (Figure S8A) whereas in aorta,
43Gap
26 300 mM partially inhibited the CCRC to 5-HT (Figure S8B).
NO and O2
N - are involved and interconnected in the
calcium and contractile responses to 5-HT
Since NO is a major element contributing to the endothelial
control of vasoreactivity, we checked the effect of L-NAME, a NO
Figure 1. Expression and function of connexins 37, 40 and 43. A shows mean values6S.E.M. of relative mRNA expression levels measured by
quantitative RT-PCR. B shows protein expression measured by Western Blot and normalized to b actin expression level. C shows immunofluorescent
labeling demonstrating the presence of Cx (red) 37 (left), 40 (middle) and 43 (right). Green shows the autofluorescent signal of the vessels and blue
the nuclei (C). C bottom are pictures of the endothelial side of opened vessels. SMC means smooth muscle cells and EC means endothelial cells. D
shows diffusion of a green fluorescent dye from the endothelium to the smooth muscle via cell-to-cell communications in basal conditions (left) and
such diffusion was blocked following one hour incubation with 300 mM
37-43Gap 27 (right). Scale bars are 15 mm. n indicates the number of rats for
quantitative RT-PCR and the number of experiments performed for Western Blot.
doi:10.1371/journal.pone.0006432.g001
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37,43Gap 27 previously
observed on the simultaneously recorded calcium and contractile
signals to 5-HT. L-NAME 100 mM reversed the blocking effect of
37,43Gap 27, 300 mM, on both the intracellular calcium concen-
tration and contraction to 5-HT (Figure 3A) whereas L-NAME
100 mM alone had no effect (Figure S9) confirming the importance
of NO in the endothelial control of the vasoreactivity through gap
junctions. We hypothesized that O2
N - production by 5-HT could
account for a reduction of the endothelial NO production leading
to an increased contraction since O2
N - is a small element which
likely passes the membranes through gap junctions and is able to
scavenge NO and/or reduce its production thus decreasing its
relaxant effect [11,27]. Indeed, poly-ethylene glycol-superoxide
dismutase (PEG-SOD) 300 U/ml and poly-ethylene glycol-
catalase (PEG-catalase) 600 U/ml, two substances which catabo-
lise O2
N -, reduced calcium and contractile responses to 5-HT and
Figure 2. Myoendothelial and/or endothelial gap junctions participate to the calcium and contractile responses to 5-HT. Typical
traces of simultaneous recordings of intracellular calcium (top panel) and contraction (bottom panel) induced by 5-HT 10 mM are shown in A. 300 mM
37-43Gap 27 was introduced into the bath where indicated. B shows the mean values6S.E.M. for the effect of
37-43Gap 27 on both the amplitude of the
calcium response to 5-HT 10 mM (top) and the percentage of contraction (bottom) in whole vessels (left) and in endothelium-denuded vessels (right).
Black columns show the responses to 5-HT in the absence of
37-43Gap 27 and white columns are the same responses in the presence of
37-43Gap 27.
Data are expressed as a delta ratio (345 nm/380 nm) for calcium signal and the percentage of contraction is related to the percentage of decrease of
the initial external diameter. n indicates the number of vessels studied. * indicates a significant difference when P,0.05.
doi:10.1371/journal.pone.0006432.g002
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Electron paramagnetic resonance (EPR) recordings demonstrated
that 5-HT produced O2
N - (Figure 4A). This O2
N - production was
prevented by PEG-SOD 300 U/ml and unchanged when the
endothelium was removed by CHAPS 0.3% (Figure 4A). We
checked that CHAPS 0.3% had no effect on its own on basal O2
N -
levels (Figure S10). Consequently, 5-HT produced O2
N - originating
from smooth muscle. Moreover, we also directly detected the
production of NO by 5-HT with EPR experiments (Figure 4B).
When the vessels were endothelium-denuded by CHAPS or
treated with L-NAME 100 mM, the production of NO by 5-HT
was abolished (Figure 4B) showing respectively that 1) NO
produced by 5-HT originates from the endothelium and 2) the
product detected by EPR is linked to NO synthases.
Finally, since, on one hand, 5-HT produced NO that induced
relaxation via cGMP production in SMC and, on the other hand,
it also produced O2
N - that antagonized NO, we measured the
cGMP content in order to determine if the overall result was in
favor of a relaxant or a contractile effect. Whereas 5-HT
significantly reduced the basal cGMP content, in the additional
presence of PEG-SOD 300 U/ml and PEG-catalase 600 U/ml, it
did increase the cGMP content (Figure 4C). This result indicates
that O2
N - produced by 5-HT in SMC decreases the NO produced
by 5-HT in EC, thus decreasing cGMP level leading to an
increased vascular contraction (Figure 5A). To the best of our
knowledge, this is the first description of a negative feedback of
smooth muscle on endothelial relaxant control of vasoreactivity.
Discussion
Our findings provide the first direct evidence of a smooth
muscle negative feedback on NO-dependent endothelial vasodi-
latation thus maintaining some contraction in vessels under
physiological pressures. In particular, we showed that the Cx 43
is expressed and functional in IPA and is necessary to develop a
sustained agonist-mediated contraction in an integrated vascular
model. Our data also support that such process involves agonist-
induced production of O2
N - in the smooth muscle and NO in the
endothelium. O2
N -, via myoendothelial junctions, reduces NO-
induced cGMP production in smooth muscle and the resulting
vessel relaxation (Figure 5).
In small vessels, gap junctions are usually mainly involved in
spontaneous oscillations of membrane potential, intracellular
calcium concentration and contraction [24,28,29]. Gap junctions
have also been shown to be largely implicated in the mediators-
and endothelium-related relaxation [5,30]. Few studies have
Figure 3. Contribution of gap junctions, O2
N - and NO in the calcium and contractile responses to 5-HT. Concentration response curves to
5-HT (0.1–100 mM) were performed simultaneously on the calcium signal (top panels) and the contraction (bottom panels). Data points are
means6S.E.M. A, 300 mM
37-43Gap 27 strongly blocked the calcium and contractile signals to 5-HT (black circles, n=7 vessels). B, PEG-SOD (300 U/ml)
and PEG-catalase (600 U/ml) also inhibited the calcium and contractile responses to 5-HT (black circles, n=7 vessels). Both
37-43Gap 27 and PEG-SOD
plus PEG-catalase effects were reversed by L-NAME 100 mM (A and B respectively, black triangles, n=6 and 9 vessels respectively). Black squares are
control dose-response curves to 5-HT (n=13–16 vessels). * indicates a significant difference when P,0.05.
doi:10.1371/journal.pone.0006432.g003
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and the results vary according to studies. Indeed, gap junction
blockers either increase or decrease the contraction and intracel-
lular calcium to phenylephrine in rat mesenteric arteries [24,29].
Interestingly, arteries that express Cx 43 to a high degree, such as
the rat aorta, are more sensitive to adrenergic agonists than those
expressing Cx 43 at a low level such as the caudal artery [30,31].
Altogether, these results are consistent with our study namely
stimulation of gap junctions, and especially Cx 43, is important to
strengthen the agonist-related vascular contraction. However, the
mechanisms involved in this regulation of the vascular tone by gap
junctions remain elusive.
Gap 26 and Gap 27 connexin-mimetic peptides have been
largely used as specific blockers of the gap junctions [24,32]. In our
hands,
37-43Gap 27 and
43Gap 26, firstly, inhibited the calcium
and contractile signals to 5-HT whereas the inactive analog
43Gap
20 had no effect and, secondly,
37-43Gap 27 prevented the
diffusion of a fluorescent dye from the endothelial cells to the
smooth muscle cells demonstrating the specificity of these blockers
on the connexins.
In vessels, Ca
2+ and inositol 1, 4, 5 trisphosphate (IP3) are
intercellular messengers that pass through the intercellular
communications and especially the myoendothelial communica-
tions [28,33]. In a model of cocultured endothelial and smooth
muscle cells, both IP3 and calcium originating in the vascular
SMC appear to cross myoendothelial communications to induce a
secondary calcium increase in endothelial cells whereas only
calcium, and not IP3, originating from EC crosses myoendothelial
junctions to generate a calcium dependent response in the vascular
SMC [33]. In an integrated model of pressurized mesenteric
arteries, such regulation by surrounding SMC via myoendothelial
gap junctions, even under basal conditions, has also been
described [28]. However, under those conditions, IP3 from SMC
increases calcium in EC and, consequently, enhances endotheli-
um-related relaxation rather than contraction. In our study, the
negative control of this secondary endothelial calcium signal linked
to relaxation allows the smooth muscle to produce a sustained
rather than a transient contraction.
There are some lines of evidence from the literature that O2
N - (1)
is produced by 5-HT in mice and bovine pulmonary arterial SMC
and (2) participates to the contraction or proliferation of SMC
[10,34]. Although, Liu and Folz [10] used an integrated model of
mouse intrapulmonary arteries, they did not address the role of
gap junctions in the contraction to 5-HT. In pulmonary artery, 5-
HT is well known to induce contraction via stimulation of 5-HT
receptors and SMC proliferation via stimulation of 5-HT
transporter and/or 5-HT receptors [6]. O2
N - production in mice
intrapulmonary arteries is insensitive to GR 127935, a selective
inhibitor of 5-HT1B/D receptor and it is sensitive to 5-HT
transporter in bovine pulmonary arterial SMC [10,35]. We did
not address the role of 5-HT transporter and/or receptor in our
model as this issue deserves future study. In the same way, Liu and
Folz suggested that O2
N - was produced via a NADPH oxidase
pathway [10] and this hypothesis could apply to our study.
O2
N - is increased in several models of hypertension including
pulmonary arterial hypertension [36,37]. Moreover, it has been
observed that increased contraction to 5-HT in aortic strips of
hypertensive rats is inhibited by the blockade of the gap junctions
[38]. Finally, pulmonary arterial hypertension is linked to an
endothelial dysfunction [39]. These data suggest that the process
we propose, namely the negative regulation of the endothelial
relaxation by the smooth muscle, could also be of great interest in
vascular pathophysiological conditions.
In conclusion, we evidenced vascular smooth muscle can
negatively control the endothelial relaxation in order to produce
a sustained contraction in small vessels at physiological pressures.
This control involves O2
N -, myoendothelial junctions and regulation
of endothelial NO function. In that respect, modifications of this
process could potentially be involved in vascular pathologies and
need to be further investigated.
Figure 4. Production of O2
N -, NO and cyclic GMP by 5-HT. A, O2
N -
production was measured by EPR spectrometry in the absence or in the
presence of 5-HT 100 mM (black column and white column respective-
ly). The production of O2
N - by 5-HT was reduced by PEG-SOD (A, grey
column) whereas it was unchanged when vessels were endothelium-
denuded by CHAPS (A, light grey column). B, EPR spectrometry also
showed an increase in NO production by 5-HT 100 mM (white column)
and an absence of NO production by 5-HT 100 mM when vessels were
endothelium-denuded by CHAPS (light grey column) or treated with L-
NAME 100 mM (grey column). C, as measured by Elisa kit, basal cyclic
GMP content (black column) was decreased by 5-HT (white column)
whereas it was increased when PEG-SOD and PEG-catalase were added
to 5-HT (light grey column). Data from EPR spectrometry are expressed
as a ratio of the amplitude of the pic (A) out of the protein
concentration of each pool of vessels in mg/ml. cGMP contents are
expressed as a ratio of the quantity of cGMP in picomoles out of the
protein concentration of each pool of vessels in mg/ml. Values are
means6S.E.M. and n indicates the number of rats tested. * indicates a
significant difference when P,0.05.
doi:10.1371/journal.pone.0006432.g004
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Figure S1 Reproducibility of two cumulative concentration-
response curves to 5-HT on the same vessel. Two CCRC to 5-HT
(0.1–100 mM)recordedonthesamevesselwithadelayofonehourin
between the two curves were similar for both calcium signal (top) and
contraction (bottom). Black squares indicate the first CCRC and the
black circles indicate the second CCRC. Data are means6S.E.M.for
8 vessels and are expressed as a delta ratio (345 nm/380 nm) for
calcium signal and a percentage of contraction (top and bottom
respectively). The percentage of contraction is related to the
percentage of the initial external diameter.
Found at: doi:10.1371/journal.pone.0006432.s001 (0.30 MB TIF)
Figure S2 Effect of endothelium removal on the relaxant effect
of carbamylcholine. Intrapulmonary arteries were preconstricted
with high potassium solution (KCl 40 mM) and then stimulated
with 10 mM carbamylcholine. Calcium and contractile signals
were simultaneously recorded (top and bottom respectively). The
experiments were performed in control vessels (black column) and
in vessels whose endothelium has been denuded with CHAPS
(white column). Data are means6S.E.M. and are expressed as a
percentage of the delta ratio (345 nm/380 nm) or a percentage of
the contraction in response to carbamylcholine 10 mM from
preconstricted vessels with KC1 40 mM (top and bottom
respectively). n indicates the number of vessels tested. * indicates
a significant difference when P,0.05.
Found at: doi:10.1371/journal.pone.0006432.s002 (0.21 MB TIF)
Figure S3 Effect of endothelium removal on the calcium and
contractile responses to high potassium solution. The calcium and
contractile signals simultaneously recorded in response to high
potassium solution (KCl 40 mM) were similar in control vessels
(black column) and in vessels whose endothelium has been
denuded with CHAPS (white column). Data are means6S.E.M.
and are expressed as a delta ratio (345 nm/380 nm) for calcium
signal and a percentage of contraction (top and bottom
respectively). n indicates the number of vessels tested.
Found at: doi:10.1371/journal.pone.0006432.s003 (0.19 MB TIF)
Figure S4 Effect of 40Gap 27 on the calcium and contractile
signals in response to 5-HT. The calcium and contractile signals
were simultaneously recorded in response to 5-HT 10 mM in the
absence (black column) or in the presence of 300 mM 40Gap 27,
Figure 5. Proposed mechanism for the negative feedback of smooth muscle on endothelial relaxant control of vasoreactivity. 5-HT
can act on both SMC and EC. Calcium increase in SMC in response to 5-HT leads to contraction whereas in EC it stimulates NO synthase and leads to
NO production. NO will stimulate guanylate cyclase which will increase cGMP production in SMC and then induce relaxation. In normal conditions, 5-
HT produces O2
N - in SMC. O2
N - passes through myoendothelial gap junctions and scavenges NO in EC thus decreasing cGMP content in SMC.
Consequently, 5-HT effect on SMC prevails over 5-HT effect on EC and will induce a contraction (A). If (1) O2
N - is degraded by SOD and catalase, and/or
(2) gap junctions are blocked, NO scavenging by O2
N - in EC will be prevented. Consequently, NO and cGMP levels will be increased thus inducing a
relaxant effect leading to a lower contraction to 5-HT in the whole vessels (B).
doi:10.1371/journal.pone.0006432.g005
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Data are means6S.E.M. and are expressed as a delta ratio
(345 nm/380 nm) for calcium signal and a percentage of
contraction (top and bottom respectively). n indicates the number
of vessels tested.
Found at: doi:10.1371/journal.pone.0006432.s004 (0.18 MB TIF)
Figure S5 Effect of 43Gap 26 on the calcium and contractile
signals in response to 5-HT. Cumulative concentration-response
curves to 5-HT (0.1–100 mM) were performed in the absence or in
the presence of 300 mM 43Gap 26, the Cx-mimetic peptide
targeted against Cx 43 (black squares and circles respectively).
Data are means6S.E.M. for 7 vessels and are expressed as a delta
ratio (345 nm/380 nm) for calcium signal and a percentage of
contraction (top and bottom respectively). * indicates a significant
difference when P,0.05.
Found at: doi:10.1371/journal.pone.0006432.s005 (0.30 MB TIF)
Figure S6 Effect of 43Gap 20 on the calcium and contractile
signals in response to 5-HT. CCRC to 5-HT (0.1–100 mM) were
performed in the absence or in the presence of 300 mM 43Gap 20,
an inactive analog of the Cx-mimetic peptide targeted against Cx
43 (black squares and circles respectively). Data are mean-
s6S.E.M. for 7 vessels and are expressed as a delta ratio
(345 nm/380 nm) for calcium signal and a percentage of
contraction (top and bottom respectively).
Found at: doi:10.1371/journal.pone.0006432.s006 (0.30 MB TIF)
Figure S7 Effect of 37-43Gap 27 on the contractile responses to
5-HT, phenylephrine, endothelin-1 and high potassium solutions.
Isometric tension measurements were recorded on intrapulmonary
arterial rings in response to cumulative concentrations of 5-HT (A)
or phenylephrine (B) or endothelin-1 (C) or in response to
increasing concentrations of potassium (KCl 4.7 - 100 mM) (D).
Contractions were recorded in the absence (black squares) or in
the presence (black circles) of 300 mM 37-43Gap 27. Data are
means6S.E.M. for 7 - 21 vessel rings and are expressed as a
percentage of the contraction to high potassium solution (KCl
80 mM). * indicates a significant difference when P,0.05.
Found at: doi:10.1371/journal.pone.0006432.s007 (0.41 MB TIF)
Figure S8 Effect of 43Gap 26 on the contractile responses to 5-
HT in renal arteries and aorta. Isometric tension measurements
were recorded on arterial rings in response to cumulative
concentrations of 5-HT in renal arteries (A) or aorta (B).
Contractions were recorded in the absence (black squares) or in
the presence (black circles) of 300 mM 43Gap 26. Data are
means6S.E.M. for 8 - 16 vessel rings and are expressed as a
percentage of the contraction to high potassium solution (KCl
80 mM). * indicates a significant difference when P,0.05.
Found at: doi:10.1371/journal.pone.0006432.s008 (0.29 MB TIF)
Figure S9 Effect of L-NAME on the simultaneously recorded
calcium and contractile signals in response to 5-HT. Cumulative
concentration-response curves to 5-HT (0.1–100 mM) were
performed in the absence or in the presence of L-NAME
100 mM, a NO synthase inhibitor (black squares and circles
respectively). Data are means6S.E.M. for 6 vessels and are
expressed as a delta ratio (345 nm/380 nm) for calcium signal and
a percentage of contraction (top and bottom respectively).
Found at: doi:10.1371/journal.pone.0006432.s009 (0.29 MB TIF)
Figure S10 Effect of endothelium removal and xanthine plus
xanthine oxidase treatment on superoxide anion production. O2N
was measured by using CMH spin trapping method and EPR
spectrometry on control vessels (black column), vessels whose
endothelium was denuded with CHAPS 0.3% (white column, top
panel) and vessels treated with xanthine 50 mM plus xanthine
oxidase 0.02 U/ml (white column, bottom panel). Data are
means6S.E.M. and are expressed as a ratio of the amplitude of
the pic (A) out of the protein concentration of each pool of vessels
in mg/ml. n indicates the number of vessels tested.
Found at: doi:10.1371/journal.pone.0006432.s010 (0.24 MB TIF)
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